Financials in USD. Standardized financial statements.
A compact view of how Precision BioSciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $34.26M | $68.70M | $48.73M | $25.10M | $115.53M | $24.29M | $22.24M | $10.88M | $6.48M | $7.01M |
| Revenue Growth? | -50.1% | +41.0% | +94.1% | -78.3% | +375.7% | +9.2% | +104.3% | +67.8% | -7.6% | 0.0% |
| Cost of Revenue? | $2.75M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $31.51M | $68.70M | $48.73M | $25.10M | $115.53M | $24.29M | $22.24M | $10.88M | $6.48M | $7.01M |
| Gross Margin? | +92.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% | +100.0% |
| Operating Expenses? | $83.66M | $94.86M | $92.46M | $87.41M | $154.91M | $134.11M | $109.44M | $58.80M | $28.34M | $15.20M |
| Operating Income? | -$52.15M | -$26.16M | -$43.74M | -$62.31M | -$39.38M | -$109.83M | -$87.20M | -$47.91M | -$21.97M | -$8.83M |
| EBITDA? | -$49.40M | $13.53M | -$32.04M | -$62.79M | -$20.27M | -$99.19M | -$87.38M | -$43.68M | -$20.42M | -$8.19M |
| Income Before Tax | -$46.61M | $7.17M | -$42.53M | -$72.91M | -$30.60M | -$109.01M | -$92.88M | -$46.04M | -$21.10M | -$8.26M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5,000 |
| Net Income? | -$46.61M | $7.17M | -$61.32M | -$111.64M | -$30.60M | -$109.01M | -$92.88M | -$46.04M | -$21.10M | -$8.25M |
| EPS? | $-3.63 | $1.05 | $-15.96 | $-38.10 | $-15.60 | $-62.85 | $-59.50 | $-28.17 | $-18.81 | $-0.49 |
| Diluted EPS? | $-3.63 | $1.04 | $-15.96 | $-38.10 | $-15.60 | $-62.85 | $-59.50 | $-28.17 | $-18.81 | $-0.49 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality